These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8595525)

  • 1. Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor.
    Klabunde RE; Calvello C
    Shock; 1995 Nov; 4(5):368-72. PubMed ID: 8595525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor.
    Laniyonu AA; Coston AF; Klabunde RE
    Shock; 1997 Jan; 7(1):49-54. PubMed ID: 8989836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    J Vasc Res; 2002; 39(3):238-45. PubMed ID: 12097822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    Eur J Pharmacol; 2000 Sep; 404(3):387-94. PubMed ID: 10996604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
    Dillon PK; Durán WN
    Circ Res; 1988 Apr; 62(4):732-40. PubMed ID: 2450695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch.
    Bouskela E; Donyo KA
    Angiology; 1997 May; 48(5):391-9. PubMed ID: 9158383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran.
    de Carvalho H; Matos JA; Bouskela E; Svensjö E
    Shock; 1999 Jul; 12(1):75-80. PubMed ID: 10468055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships.
    Dillon PK; Fitzpatrick MF; Ritter AB; Durán WN
    Inflammation; 1988 Dec; 12(6):563-73. PubMed ID: 3220518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculatory dynamics of neuropeptide Y.
    Kim D; Durán WR; Kobayashi I; Daniels AJ; Durán WN
    Microvasc Res; 1994 Jul; 48(1):124-34. PubMed ID: 7990718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP).
    Rylander R; Beijer L; Lantz RC; Burrell R; Sedivy P
    Int Arch Allergy Appl Immunol; 1988; 86(3):303-7. PubMed ID: 3403044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelet-activating factor in the pulmonary response to inhaled bacterial endotoxin.
    Lantz RC; Keller GE; Burrell R
    Am Rev Respir Dis; 1991 Jul; 144(1):167-72. PubMed ID: 2064124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
    Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
    Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
    Kim DD; Ramírez MM; Durán WN
    Microvasc Res; 2000 Jan; 59(1):7-13. PubMed ID: 10625566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NW-nitro-L-arginine and dexamethasone on early events following lipopolysaccharide injection: observations in the hamster cheek pouch microcirculation.
    Bouskela E; Rubanyi GM
    Shock; 1994 May; 1(5):347-53. PubMed ID: 7743337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.